Lepu Medical Tech Beijing (300003) - Cash Flow Conversion Efficiency
Based on the latest financial reports, Lepu Medical Tech Beijing (300003) has a cash flow conversion efficiency ratio of 0.024x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CN¥425.84 Million ≈ $62.31 Million USD) by net assets (CN¥17.75 Billion ≈ $2.60 Billion USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See debt-free asset ratio of Lepu Medical Tech Beijing to measure how much of total assets are equity-financed.
Lepu Medical Tech Beijing - Cash Flow Conversion Efficiency Trend (2006–2025)
This chart illustrates how Lepu Medical Tech Beijing's cash flow conversion efficiency has evolved over time, based on yearly financial data. Check 300003 cash flow quality index to evaluate the quality of earnings relative to operating cash generation.
Lepu Medical Tech Beijing Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Lepu Medical Tech Beijing ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
CECEP Wind-Power Corp Co Ltd
SHG:601016
|
0.092x |
|
CommVault Systems Inc
NASDAQ:CVLT
|
0.019x |
|
Premium Brands Holdings Corporation
TO:PBH
|
-0.003x |
|
APERAM S.A. NY SHS/1 O.N.
F:7AAN
|
-0.003x |
|
EASYJET PLC SP.ADR NEW/4
F:EJTS
|
N/A |
|
Aperam SA
AS:APAM
|
-0.003x |
|
Incitec Pivot Ltd
AU:IPL
|
0.064x |
|
SkyWest Inc
NASDAQ:SKYW
|
0.053x |
Annual Cash Flow Conversion Efficiency for Lepu Medical Tech Beijing (2006–2025)
The table below shows the annual cash flow conversion efficiency of Lepu Medical Tech Beijing from 2006 to 2025. For the full company profile with market capitalisation and key ratios, see Lepu Medical Tech Beijing stock valuation.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-12-31 | CN¥17.76 Billion ≈ $2.60 Billion |
CN¥1.52 Billion ≈ $221.97 Million |
0.085x | +94.63% |
| 2024-12-31 | CN¥16.74 Billion ≈ $2.45 Billion |
CN¥734.64 Million ≈ $107.50 Million |
0.044x | -22.47% |
| 2023-12-31 | CN¥17.50 Billion ≈ $2.56 Billion |
CN¥990.36 Million ≈ $144.92 Million |
0.057x | -66.80% |
| 2022-12-31 | CN¥16.37 Billion ≈ $2.40 Billion |
CN¥2.79 Billion ≈ $408.37 Million |
0.170x | -31.67% |
| 2021-12-31 | CN¥12.27 Billion ≈ $1.80 Billion |
CN¥3.06 Billion ≈ $448.07 Million |
0.249x | +25.80% |
| 2020-12-31 | CN¥10.54 Billion ≈ $1.54 Billion |
CN¥2.09 Billion ≈ $305.79 Million |
0.198x | -20.24% |
| 2019-12-31 | CN¥8.00 Billion ≈ $1.17 Billion |
CN¥1.99 Billion ≈ $291.24 Million |
0.249x | +8.96% |
| 2018-12-31 | CN¥6.58 Billion ≈ $962.28 Million |
CN¥1.50 Billion ≈ $219.57 Million |
0.228x | +75.60% |
| 2017-12-31 | CN¥7.03 Billion ≈ $1.03 Billion |
CN¥913.13 Million ≈ $133.62 Million |
0.130x | +12.93% |
| 2016-12-31 | CN¥6.01 Billion ≈ $879.94 Million |
CN¥691.89 Million ≈ $101.25 Million |
0.115x | +40.74% |
| 2015-12-31 | CN¥5.34 Billion ≈ $781.21 Million |
CN¥436.46 Million ≈ $63.87 Million |
0.082x | -22.72% |
| 2014-12-31 | CN¥3.29 Billion ≈ $481.81 Million |
CN¥348.32 Million ≈ $50.97 Million |
0.106x | -7.14% |
| 2013-12-31 | CN¥2.89 Billion ≈ $423.55 Million |
CN¥329.76 Million ≈ $48.25 Million |
0.114x | +12.59% |
| 2012-12-31 | CN¥2.62 Billion ≈ $383.16 Million |
CN¥264.96 Million ≈ $38.77 Million |
0.101x | -18.63% |
| 2011-12-31 | CN¥2.34 Billion ≈ $342.64 Million |
CN¥291.20 Million ≈ $42.61 Million |
0.124x | -31.34% |
| 2010-12-31 | CN¥2.07 Billion ≈ $302.36 Million |
CN¥374.25 Million ≈ $54.76 Million |
0.181x | +32.64% |
| 2009-12-31 | CN¥1.76 Billion ≈ $256.95 Million |
CN¥239.79 Million ≈ $35.09 Million |
0.137x | -62.98% |
| 2008-12-31 | CN¥511.23 Million ≈ $74.81 Million |
CN¥188.59 Million ≈ $27.60 Million |
0.369x | +130.77% |
| 2007-12-31 | CN¥383.88 Million ≈ $56.17 Million |
CN¥61.37 Million ≈ $8.98 Million |
0.160x | -68.34% |
| 2006-12-31 | CN¥115.51 Million ≈ $16.90 Million |
CN¥58.32 Million ≈ $8.53 Million |
0.505x | -- |
About Lepu Medical Tech Beijing
Lepu Medical Technology (Beijing) Co., Ltd., together with its subsidiaries, engages in the research, development, and manufacturing of cardiac interventional medical devices in China and internationally. The company operates through three segments: Medical Devices; Pharmaceuticals; and Medical Services and Health Management. It offers medical devices, including cardiovascular devices, in vitro d… Read more